Ligand Enters Into OmniAb® Platform License Agreement with Tizona Therapeutics

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. META
2. P
3. ORCL
4. OKTA
5. MCD
6. AKAM
7. SPY
8. COST
9. MGM
10. NVDA

Go back to Ligand Enters Into OmniAb® Platform License Agreement with Tizona Therapeutics
LIGAND PHARMA (NASDAQ: LGND) Delayed: 299.04 --0 (-0%)
Previous Close $299.04    52 Week High $139.79 
Open $299.04    52 Week Low $82.07 
Day High $299.04    P/E 695.44 
Day Low $299.04    EPS $0.43 
Volume 862